BECTON DICKINSON & CO is 35.7x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($40.51 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KMTS | BDX |
|---|---|---|
| Market cap | $1.13 B | $40.51 B |
| US-listed rank | #2543 | #375 |
| Revenue (latest FY) | $59.81M | $21.84B |
| Net income (latest FY) | -$113.81M | $1.68B |
| Net margin | -190.3% | 7.7% |
| P/E (trailing FY) | - | 24.1 |
| SEC filings | 105 | 3,027 |
BECTON DICKINSON & CO is 35.7x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($40.51 B vs $1.13 B).
In their latest fiscal years, KESTRA MEDICAL TECHNOLOGIES, LTD. reported $59.81M in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: KESTRA MEDICAL TECHNOLOGIES, LTD. and BECTON DICKINSON & CO, or browse the full rankings.